Ajay Raju - 31 Dec 2024 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
31 Dec 2024, 17:00:07 UTC
Next SEC filing
24 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ajay Raju

Key filing fact

Ajay Raju filed Form 3 for Medicus Pharma Ltd. (MDCX) on 31 Dec 2024.

Key facts

  • This page summarizes Ajay Raju's Form 3 filing for Medicus Pharma Ltd. (MDCX).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 31 Dec 2024, 17:00.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,000,000
Date
31 Dec 2024
Ownership
See Footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares are held of record by 215 Capital Togo PHL Fund I, LP ("215 Capital"). Togo PHL Management LLC (the "Management Company") has been delegated the responsibilities of the general partner of 215 Capital, Togo PHL Fund I GP, LLC, including the voting and dispositive power over the shares reported herein. Mr. Ajay Raju is responsible for managing the affairs of the Management Company including the voting and dispositive power over the shares reported herein. Mr. Raju therefore may be deemed to have voting and dispositive power over the shares reported herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .